BridgeMD
New treatment option for Smoking Behaviors
Official title Influence of Authorized Smokeless Tobacco Product Modified Risk Claims I: Consumer Product Demand
ClinicalTrials.gov ID: NCT07102082
What this study is testing
- What it's testing
- To explore consumer responses to the announcement and implementation of new modified risk claims for Copenhagen and General Snus (brands of smokeless tobacco (ST) products) using a series of complementary and innovative research activities and methods.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 21 and older. Healthy volunteers may be eligible.
You may be able to join if
- Residing in one of the 8 counties of Western New York (Erie, Niagara, Cattaraugus, Chautauqua, Allegheny, Livingston, Genesee, Orleans, Wyoming).
- Smoke cigarettes every day, at least 5 cigarettes per day, for at least 1 year.
- Open to trying a non-combusted oral tobacco product.
- Have access to a device (ie: computer/tablet/smartphone) with internet capabilities to participate in an online survey study.
- Have the ability to read, write, and communicate in English.
You likely can't join if
- Plan to quit smoking in the next 30 days.
- Use of smokeless tobacco at least weekly in the last 6 months.
- Lifetime use (that is, ever used at any time prior to the study) of Copenhagen or General Snus.
- Unwilling or unable to follow protocol requirements.
- Pregnant or planning to become pregnant (by self report)
See the full eligibility criteria
- Residing in one of the 8 counties of Western New York (Erie, Niagara, Cattaraugus, Chautauqua, Allegheny, Livingston, Genesee, Orleans, Wyoming).
- Smoke cigarettes every day, at least 5 cigarettes per day, for at least 1 year.
- Open to trying a non-combusted oral tobacco product.
- Have access to a device (ie: computer/tablet/smartphone) with internet capabilities to participate in an online survey study.
- Have the ability to read, write, and communicate in English.
- Participant must understand the investigational nature of this study and an Independent Ethics Committee/Institutional Review Board approved information sheet prior to receiving any study related procedure
- Plan to quit smoking in the next 30 days.
- Use of smokeless tobacco at least weekly in the last 6 months.
- Lifetime use (that is, ever used at any time prior to the study) of Copenhagen or General Snus.
- Unwilling or unable to follow protocol requirements.
- Pregnant or planning to become pregnant (by self report)
The study team makes the final eligibility decision.
Where it's taking place
- Buffalo, New York, United States
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 21 years and older. Healthy volunteers may be eligible. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Buffalo, New York, United States. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.